This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Bromodomain-containing protein BRPF1 is a therapeutic target for liver cancer
Communications Biology Open Access 20 July 2021
-
Chromatin modifiers and the promise of epigenetic therapy in acute leukemia
Leukemia Open Access 10 March 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Accession codes
References
Sun T, Wu E . Acute monoblastic leukemia with t(8;16): a distinct clinicopathologic entity; report of a case and review of the literature. Am J Hematol 2001; 66: 207–212.
Borrow J, Stanton Jr VP, Andresen JM, Becher R, Behm FG, Chaganti RS et al. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet 1996; 14: 33–41.
Giles RH, Dauwerse JG, Higgins C, Petrij F, Wessels JW, Beverstock GC et al. Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16). Leukemia 1997; 11: 2087–2096.
Chaffanet M, Mozziconacci MJ, Fernandez F, Sainty D, Lafage-Pochitaloff M, Birnbaum D et al. A case of inv(8)(p11q24) associated with acute myeloid leukemia involves the MOZ and CBP genes in a masked t(8;16). Genes Chromosomes Cancer 1999; 26: 161–165.
Schmidt HH, Strehl S, Thaler D, Strunk D, Sill H, Linkesch W et al. RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: breakpoint cluster region and clinical implications. Leukemia 2004; 18: 1115–1121.
Crowley JA, Butler MS, Ronnenburg MJ, Ament CN, Meekins JS, Ning Y . Development of a dual-color fluorescence in situ hybridization probe set on chromosome 6q to improve cytogenetic diagnosis of lymphoid malignancies. Cancer Genet Cytogenet 2005; 157: 78–81.
Panagopoulos I, Isaksson M, Lindvall C, Bjorkholm M, Ahlgren T, Fioretos T et al. RT-PCR analysis of the MOZ-CBP and CBP-MOZ chimeric transcripts in acute myeloid leukemias with t(8;16)(p11;p13). Genes Chromosomes Cancer 2000; 28: 415–424.
Rozman M, Camos M, Colomer D, Villamor N, Esteve J, Costa D et al. Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation. Genes Chromosomes Cancer 2004; 40: 140–145.
Acknowledgements
We thank the staff of our cytogenetics laboratory for karyotype analysis. APR is a Clinical Scholar of the Leukemia and Lymphoma Society. This study was supported by an intramural research grant from the School of Medicine, University of Maryland.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Crowley, J., Wang, Y., Rapoport, A. et al. Detection of MOZ-CBP fusion in acute myeloid leukemia with 8;16 translocation. Leukemia 19, 2344–2345 (2005). https://doi.org/10.1038/sj.leu.2403971
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403971
This article is cited by
-
Bromodomain-containing protein BRPF1 is a therapeutic target for liver cancer
Communications Biology (2021)
-
Chromatin modifiers and the promise of epigenetic therapy in acute leukemia
Leukemia (2014)
-
Histone-modifying enzymes: their role in the pathogenesis of acute leukemia and their therapeutic potential
International Journal of Hematology (2013)